1. Home
  2. Product Labeler Index - L
  3. Company Labeler Name: Lonza Biologics, Inc.

NDC Product Labeler Lonza Biologics, Inc.

Lonza Biologics, Inc. labeler's code is 65686. The labeler has 27 products that have an assigned National Drug Code.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Product Type Status
67643-0012 Infliximab 40.0 Mg/ml Drug SubstanceLiquidDrug For Further ProcessingUNFINISHED
67643-0015 ReslizumabLiquidDrug For Further ProcessingUNFINISHED
67643-0016 OfatumumabLiquidDrug For Further ProcessingUNFINISHED
67643-0017 Asfotase AlfaLiquidDrug For Further ProcessingUNFINISHED
67643-0018 ObiltoxaximabLiquidDrug For Further ProcessingUNFINISHED
67643-0019 BezlotoxumabLiquidDrug For Further ProcessingUNFINISHED
67643-0020 ImigluceraseLiquidDrug For Further ProcessingUNFINISHED
67643-0021 NivolumabLiquidDrug For Further ProcessingUNFINISHED
67643-0022 TrastuzumabLiquidDrug For Further ProcessingUNFINISHED
67643-0023 Vedolizumab IvLiquidDrug For Further ProcessingUNFINISHED
67643-0024 Eftrenonacog AlfaLiquidDrug For Further ProcessingUNFINISHED
67643-0028 FremanezumabLiquidDrug For Further ProcessingUNFINISHED
67643-0029 TafasitamabLiquidDrug For Further ProcessingUNFINISHED
67643-0031 Efgartigimod Drug SubstanceLiquidDrug For Further ProcessingUNFINISHED
67643-0032 IsatuximabLiquidDrug For Further ProcessingUNFINISHED
67643-0033 MabyLiquidDrug For Further ProcessingUNFINISHED
67643-0034 Vedolizumab ScLiquidDrug For Further ProcessingUNFINISHED
67643-5008 Lisocabtagene Maraleucel Lentivirus VectorSuspensionDrug For Further ProcessingUNFINISHED
67643-7000 OcrelizumabLiquidDrug For Further ProcessingUNFINISHED
67643-7001 OcrelizumabLiquidDrug For Further ProcessingUNFINISHED
67643-7002 PertuzumabLiquidDrug For Further ProcessingUNFINISHED
67643-7003 PertuzumabLiquidDrug For Further ProcessingUNFINISHED
67643-7004 PertuzumabLiquidDrug For Further ProcessingUNFINISHED
67643-7005 RituximabLiquidDrug For Further ProcessingUNFINISHED
67643-7006 RituximabLiquidDrug For Further ProcessingUNFINISHED
67643-7007 TocilizumabLiquidDrug For Further ProcessingUNFINISHED
67643-7008 TocilizumabLiquidDrug For Further ProcessingUNFINISHED